Prognostic value of surgical margin status for biochemical recurrence following radical prostatectomy

Japanese Journal of Clinical Oncology

Volumn 38, Issue 1, 2008, Pages 31-35

  Hashimoto, Kohei ^a   Masumori, Naoya ^a   Takei, Fumiyasu ^a   Fukuta, Fumimasa ^a   Takahashi, Atsushi ^b   Itoh, Naoki ^a   Hasegawa, Tadashi ^a   Tsukamoto, Taiji ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Hakodate Goryokaku Hospital   (Japan)

Author keywords

Prostate cancer; Radical prostatectomy; Recurrence; Surgical margin

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PREDICTION; PREOPERATIVE EVALUATION; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSTATE CANCER; PROSTATECTOMY; RECURRENCE RISK; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL RATE;

ADULT; AGED; DISEASE-FREE SURVIVAL; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 39049136009     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hym135     Document Type: Article

References (19)

1. Swindle P, Eastham JA, Ohori M, Kattan MW, Wheeler T, Maru N, et al. Do margins matter? The prognostic significance of positive surgical margins in radical prostatoctomy specimens. J Urol 2005;174:903-7.
2. Eastham JA, Kattan MW, Riedel E, Begg CB, Wheeler TM, Gerigk C, et al. Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens. J Urol 2003; 170:2292-5.
3. Pettus JA, Weight CJ, Thompson CJ, Middleton RG, Stephenson RA. Biochemical failure in men following radical retropubic prostatectomy: impact of surgical margin status and location. J Urol 2004;172: 129-32.
4. Karakiewicz PI, Eastham JA, Graefen M, Cagiannos I, Stricker PD, Klein E, et al. Prognostic impact of positive surgical margins in surgically treated prostate cancer: Multi-institutional assessment of 5831 patients. Urology 2005;66:1245-50.
5. Vis AN, Schroder FH, van der Kwast TH. The actual value of the surgical margin status as a predictor of disease progression in men with early prostate cancer. Eur Urol 2006;50:258-65.
6. Simon MA, Kim S, Soloway MS. Prostate specific antigen recurrence rates are low after radical retropubic prostatectomy and positive margins. J Urol 2006;175:140-4. Discussion in 2006;175:144-5.
7. Ohori M, Wheeler TM, Kattan MW, Goto Y, Scardino PT. Prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol 1995;154:1818-24.
8. Salomon L, Anastasiadis AG, Johnson CW, McKiernan JM, Goluboff ET, Abbou CC, et al. Seminal vesicle involvement after radical prostatectomy: predicting risk factors for progression. Urology 2003;62:304-9.
9. Freedland SJ, Aronson W, Presti JC Jr, Kane CJ, Terris MI, Elashoff D, et al. Should a positive surgical margin following radical prostatectomy be pathological gage T2 or T3? Results from the SEARCH database. J Urol 2003; 169:2142-6.
10. Collette L, van Poppel H, Bolla M, vas Cangh P, Vekemans K, Da Pozzo L, et al. Patients at high risk of progression after radical prostatectomy: do they all benefit, from immediate post-operative irradiation? (EORTC trial 22911). Eur J Cancer 2005;41:2662-72.
11. Walsh PC. Anatomical radical Prostatectomy: Evolusion of the surgical technique. J Urol 1998;160:2418-24.
12. Malavaud B, Villers A, Ravery V, Tollon C, Rischmann P, Charlet JP, et al. Role of preoperative positive apical biopsies in the prediction of specimen-confined prostate cancer after radical retropubic prostatectomy: A multi-institutional study. Eur Urol 2000;37:281-8.
13. Park EL, Dalkin B, Escobar C, Nagle RB. Site-specific positive margins at radical prostatectomy: Assessing, cancer-control benefits of wide excision of the neurovascular bundle on a side with cancer on biopsy. BJU Int 2003;91:219-22.
14. Khan MA, Partin AW, Mangold LA, Epstein JL Walsh PC. Probability of biochemical recurrence by analysis of pathologic stage, Gleason score, and margin status for localized prostate cancer. Urology 2003;62:866-71.
15. Freedland SJ, Kane CJ, Presti JC Jr, Terris NK Amling CL, Dorey F, et al. Comparison of preoperative prostate specific antigen density and prostate specific antigen for predicting recurrence after radical prostatectomy: Results from the search data base. J Urol 2003;169: 969-73.
16. Freedland SJ, Csathy GS, Dorey F, Aronson WJ. Percent prostate needle biopsy tissue with cancer is more predictive of biochemical failure or adverse pathology after radical prostatectomy than prostate specific antigen or Gleason score. J Urol 2002;167:516-20.
17. Bolla, M, van Poppel H, Collette L, van Cangh P, Vekemans K, Da Pozzo L, et al. Postoperative radiotherapy after radical prostatectomy: A randomised controlled trial (EORTC trial 22911). Lancet 2005;366:572-8.
18. Thompson IM Jr, Tangen CM, Paradelo J, Lucia MS, Miller G, Troyer D, et al. Adjuvant radiotherapy for pathologically advanced prostate cancer: A randomized clinical. trial. JAMA 2006;296:2329-35.
19. Wirth MP, Weissbach L, Marx FJ, Heckl W, Jellinghaus W, Riedmiller H, et al. Prospective randomized trial comparing flutamide as adjuvant treatment versus observation after radical prostatectomy for locally advanced, lymph node-negative prostate cancer. Eur Urol 2004;45:267-70.